Event

Agenus and Dr. Steven O’Day Participate in B. Riley SITC 2020 Immuno-Oncology Virtual Panel

November 12, 2020 at 1:00 PM EST

 

Panel #2: Next-Gen Checkpoint Inhibitors (CPI) and Co-Stimulatory Agonists Finally Ready for Prime Time

Speakers:

  • Steven O’Day, MD – Executive Directo of the John Wayne Cancer Institute
  • Jennifer Buell, PhD – President and COO of Agenus
  • Patrick Jordan – COO of AgenTus Therapeutics
Dial-in for replay: 800-332-6854 or 973-528-0005; Conference ID: 311564

 

Panel #3: Cell Therapy 2.0: Transforming Immune Cells to Mainstream Cancer Treatments

Speakers:

  • Jennifer Buell, PhD – President & COO of Agenus
  • Patrick Jordan – COO of AgenTus Therapeutics
Dial-in for replay: 800-332-6854 or 973-528-0005; Conference ID: 650564